Evigrade

D-aspartic acid (DAA)

D-enantiomer of aspartic acid, sport and biohacking supplement. AEMPS does not register as medicine

ATC code: A16AA-D-ASPARTIC

Brand names – supplements: Now D-Aspartic Acid, Primaforce DAA, Bulk D-Aspartic Acid, Cellucor DAASupplements are not tested in clinical trials and are not registered as medications.

Updated · Methodology

Marketing claims without evidence base

The drug is promoted for these uses outside international guidelines. Each entry below is analyzed against AEMPS, FDA, EMA, Cochrane and major RCTs.

D

Male fertility and sperm quality

Not recommended

D-aspartic acid is marketed to improve semen analysis on the strength of D'Aniello 2012, where sperm concentration and motility roughly doubled over 90 days in 60 subfertile men. That study was open-label, had no placebo and no randomization, and appeared in a journal not indexed in PubMed, so it cannot establish the effect. A 2017 systematic review by Roshanzamir and Safavi found only four human trials and rated the evidence sparse and inconsistent, while a placebo-controlled trial in trained men (Melville 2017) showed no rise in testosterone. The one positive randomized placebo-controlled trial (GamalEl Din 2025) combined D-aspartic acid with ubiquinol and zinc, so its benefit cannot be attributed to the amino acid alone. No serious adverse effects are documented at roughly 2.66 g per day, but a fertility benefit remains unproven.

ICD-10: N46.9 · ICD-11: GB04

F

Low testosterone in men (supplement marketing)

Not recommended

D-aspartic acid is a popular «natural testosterone booster» in biohacking and sport segments, sold on the Topo 2009 paper about +42% testosterone over 12 days. Modern RCTs refute the result: Melville 2017 (PLoS One) in 22 trained men showed no change in total or free testosterone with DAA 6 g/day over 12 weeks vs placebo. Willoughby 2013 in 20 men at 3 g/day for 28 days also showed no change. Moreover, Melville 2015 found that 6 g/day lowered total testosterone, so the supplement does the opposite of what it promises. Endocrine Society 2018 in confirmed hypogonadism recommends testosterone replacement therapy; DAA is in no international guideline. If DAA was recommended for «low testosterone» without proper workup, consider seeking a second opinion from an endocrinologist.

ICD-10: E29.1 · ICD-11: 5A81.1

F

Muscle mass gain (bodybuilding self-use)

Not recommended

DAA is sold in pre-workout formulas and «testosterone boosters» as a muscle gain product on the hormone-mediated hypertrophy hypothesis. No evidence base: Willoughby 2013 and Melville 2017 RCTs in trained men showed no clinically meaningful DAA effect on lean body mass and strength. For muscle gain IOC 2018 and ISSN 2015 list creatine monohydrate (3–5 g/day), adequate protein (1.6–2.2 g/kg), progressive overload and caloric surplus; DAA is not in the IOC-approved sports supplement list.

How to read tiers A–F
  • AStrong evidence – first or second line in international guidelines
  • BRecommended in selected cases
  • CStudy data contradict each other
  • DBenefit not proven, no documented harm
  • FDocumented harm, or risk without benefit

Mechanism of action

D-aspartic acid is the D-form of aspartate; unlike the standard L-form it is not used in protein synthesis. In animal models D-aspartic acid accumulates in hypothalamus and testes, increases gonadotropin-releasing hormone, LH and testosterone synthesis. The human transfer hypothesis rests on Topo 2009 (Reprod Biol Endocrinol) in 23 men: DAA 3.12 g/day × 12 days raised total testosterone by 42% vs placebo. However, subsequent RCTs with better methodology refuted the result: Melville 2017 (Nutr Res) in 24 trained men showed no changes in total or free testosterone with DAA 6 g/day × 14 days. Current sports science consensus: DAA does not work as a «testosterone booster».

Safety

Contraindications

  • Pregnancy and lactation
  • Children and adolescents (theoretical endocrine effect)
  • Hormone-sensitive prostate, breast tumours
  • Epilepsy (D-aspartic acid is NMDA receptor agonist, theoretically lowers seizure threshold)

Serious adverse effects

  • Seizure threshold reduction in predisposed patients (via NMDA receptor agonism)
  • Hormone-sensitive tumour growth promotion (theoretical risk)

Common adverse effects

  • Nausea
  • Irritability and anxiety
  • Headache

Pregnancy: can you take D-aspartic acid (DAA)?

No RCT data in pregnancy. AEMPS does not register. Avoid in pregnancy.

Breastfeeding: can you take D-aspartic acid (DAA)?

No data on milk transfer. Lactating women should avoid.

Reference information, not a clinical decision. Discuss feeding pauses or changes with your physician or an IBCLC.

Check interaction with another drug

Opens the checker prefilled with this drug. Pick the second one from your regimen.

Open checker

Summary of a multi-drug list →

Medicine list: everything you take in one place →

Frequently asked

What is D-aspartic acid (DAA) used for?

D-aspartic acid (DAA) is evaluated for the following indications with varying evidence strength: Male fertility and sperm quality (evidence tier D), Low testosterone in men (supplement marketing) (evidence tier F), Muscle mass gain (bodybuilding self-use) (evidence tier F). See the full indication matrix with dosing and citations above on this page.

What are the side effects of D-aspartic acid (DAA)?

Common side effects of D-aspartic acid (DAA) (≥ 1 in 100): Nausea, Irritability and anxiety, Headache. See the Safety section for uncommon and serious reactions.

Is D-aspartic acid (DAA) safe during pregnancy?

No RCT data in pregnancy. AEMPS does not register. Avoid in pregnancy.

Is D-aspartic acid (DAA) compatible with breastfeeding?

No data on milk transfer. Lactating women should avoid.

Who should not take D-aspartic acid (DAA)?

D-aspartic acid (DAA) is contraindicated in: Pregnancy and lactation; Children and adolescents (theoretical endocrine effect); Hormone-sensitive prostate, breast tumours; Epilepsy (D-aspartic acid is NMDA receptor agonist, theoretically lowers seizure threshold). Full list in the Safety section.

Other drugs in this group

Gamma-aminobutyric acid (GABA), Glutathione, Beta-hydroxy beta-methylbutyrate (HMB), L-arginine, Levocarnitine (L-carnitine), L-theanine, N-acetyl-L-tyrosine, Astragalus root (Astragalus membranaceus; Huang Qi in traditional Chinese medicine)